Report Detail
Global (United States, European Union and China) Engineered T Cells Market Research Report 2019-2025
- RnM3460376 |
- 27 May, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
In 2019, the market size of Engineered T Cells is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Engineered T Cells.
This report studies the global market size of Engineered T Cells, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Engineered T Cells sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Autolus Limited
Bellicum Pharmaceuticals
Cells Medica
Elli Lilly and Company
Gilead Sciences
Juno Therapeutics
Novartis
Oxford Biomedica
Pfizer
Precision Bioscience
Redmile Group
Seeking Alpha
Unum Therapeutics
Market Segment by Product Type
Tumor Infiltrating Lymphocytes
T Cell Receptor {TCR}
Chimeric Antigen Receptor (CAR)
Market Segment by Application
Hospitals
Cancer Research Centers
Clinics
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Engineered T Cells status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Engineered T Cells manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Engineered T Cells are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Engineered T Cells Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Tumor Infiltrating Lymphocytes
- 1.3.3 T Cell Receptor {TCR}
- 1.3.4 Chimeric Antigen Receptor (CAR)
- 1.4 Market Segment by Application
- 1.4.1 Global Engineered T Cells Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Cancer Research Centers
- 1.4.4 Clinics
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Engineered T Cells Market Size
- 2.1.1 Global Engineered T Cells Revenue 2014-2025
- 2.1.2 Global Engineered T Cells Sales 2014-2025
- 2.2 Engineered T Cells Growth Rate by Regions
- 2.2.1 Global Engineered T Cells Sales by Regions 2014-2019
- 2.2.2 Global Engineered T Cells Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Engineered T Cells Sales by Manufacturers
- 3.1.1 Engineered T Cells Sales by Manufacturers 2014-2019
- 3.1.2 Engineered T Cells Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Engineered T Cells Revenue by Manufacturers (2014-2019)
- 3.2.2 Engineered T Cells Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Engineered T Cells Market Concentration Ratio (CR5 and HHI)
- 3.3 Engineered T Cells Price by Manufacturers
- 3.4 Key Manufacturers Engineered T Cells Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Engineered T Cells Market
- 3.6 Key Manufacturers Engineered T Cells Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Tumor Infiltrating Lymphocytes Sales and Revenue (2014-2019)
- 4.1.2 T Cell Receptor {TCR} Sales and Revenue (2014-2019)
- 4.1.3 Chimeric Antigen Receptor (CAR) Sales and Revenue (2014-2019)
- 4.2 Global Engineered T Cells Sales Market Share by Type
- 4.3 Global Engineered T Cells Revenue Market Share by Type
- 4.4 Engineered T Cells Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Engineered T Cells Sales by Application
6 United States
- 6.1 United States Engineered T Cells Breakdown Data by Company
- 6.2 United States Engineered T Cells Breakdown Data by Type
- 6.3 United States Engineered T Cells Breakdown Data by Application
7 European Union
- 7.1 European Union Engineered T Cells Breakdown Data by Company
- 7.2 European Union Engineered T Cells Breakdown Data by Type
- 7.3 European Union Engineered T Cells Breakdown Data by Application
8 China
- 8.1 China Engineered T Cells Breakdown Data by Company
- 8.2 China Engineered T Cells Breakdown Data by Type
- 8.3 China Engineered T Cells Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Engineered T Cells Breakdown Data by Company
- 9.2 Rest of World Engineered T Cells Breakdown Data by Type
- 9.3 Rest of World Engineered T Cells Breakdown Data by Application
- 9.4 Rest of World Engineered T Cells Breakdown Data by Countries
- 9.4.1 Rest of World Engineered T Cells Sales by Countries
- 9.4.2 Rest of World Engineered T Cells Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Autolus Limited
- 10.1.1 Autolus Limited Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Engineered T Cells
- 10.1.4 Engineered T Cells Product Introduction
- 10.1.5 Autolus Limited Recent Development
- 10.2 Bellicum Pharmaceuticals
- 10.2.1 Bellicum Pharmaceuticals Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Engineered T Cells
- 10.2.4 Engineered T Cells Product Introduction
- 10.2.5 Bellicum Pharmaceuticals Recent Development
- 10.3 Cells Medica
- 10.3.1 Cells Medica Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Engineered T Cells
- 10.3.4 Engineered T Cells Product Introduction
- 10.3.5 Cells Medica Recent Development
- 10.4 Elli Lilly and Company
- 10.4.1 Elli Lilly and Company Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Engineered T Cells
- 10.4.4 Engineered T Cells Product Introduction
- 10.4.5 Elli Lilly and Company Recent Development
- 10.5 Gilead Sciences
- 10.5.1 Gilead Sciences Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Engineered T Cells
- 10.5.4 Engineered T Cells Product Introduction
- 10.5.5 Gilead Sciences Recent Development
- 10.6 Juno Therapeutics
- 10.6.1 Juno Therapeutics Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Engineered T Cells
- 10.6.4 Engineered T Cells Product Introduction
- 10.6.5 Juno Therapeutics Recent Development
- 10.7 Novartis
- 10.7.1 Novartis Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Engineered T Cells
- 10.7.4 Engineered T Cells Product Introduction
- 10.7.5 Novartis Recent Development
- 10.8 Oxford Biomedica
- 10.8.1 Oxford Biomedica Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Engineered T Cells
- 10.8.4 Engineered T Cells Product Introduction
- 10.8.5 Oxford Biomedica Recent Development
- 10.9 Pfizer
- 10.9.1 Pfizer Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Engineered T Cells
- 10.9.4 Engineered T Cells Product Introduction
- 10.9.5 Pfizer Recent Development
- 10.10 Precision Bioscience
- 10.10.1 Precision Bioscience Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Engineered T Cells
- 10.10.4 Engineered T Cells Product Introduction
- 10.10.5 Precision Bioscience Recent Development
- 10.11 Redmile Group
- 10.12 Seeking Alpha
- 10.13 Unum Therapeutics
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Engineered T Cells Sales Channels
- 11.2.2 Engineered T Cells Distributors
- 11.3 Engineered T Cells Customers
12 Market Forecast
- 12.1 Global Engineered T Cells Sales and Revenue Forecast 2019-2025
- 12.2 Global Engineered T Cells Sales Forecast by Type
- 12.3 Global Engineered T Cells Sales Forecast by Application
- 12.4 Engineered T Cells Forecast by Regions
- 12.4.1 Global Engineered T Cells Sales Forecast by Regions 2019-2025
- 12.4.2 Global Engineered T Cells Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Engineered T Cells . Industry analysis & Market Report on Engineered T Cells is a syndicated market report, published as Global (United States, European Union and China) Engineered T Cells Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Engineered T Cells market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
